Objective: The aim of this study was to validate the newly developed shortened Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55) in a sample of children with drug-resistant epilepsy. Methods: Data came from 136 children enrolled in the Impact of Pediatric Epilepsy Surgery on Health-Related Quality of Life Study (PEPSQOL), a multicenter prospective cohort study. Confirmatory factor analysis was used to assess the higher-order factor structure of the QOLCE-55. Convergent and divergent validity was assessed by correlating subscales of the KIDSCREEN-27 with the QOLCE-55. Measurement equivalence of the QOLCE-55 was evaluated using multiple-group confirmatory factor analysis of children with drug-resistant epilepsy from PEPSQOL versus children with newonset epilepsy from HERQULES (Health-Related Quality of Life in Children with Epilepsy Study). Significance: The findings provide support for the factor structure of the QOLCE-55 and contribute to its robust psychometric profile as a reliable and valid measure. Researchers and health practitioners should consider the QOLCE-55 as a viable option for reducing respondent burden when assessing health-related quality of life in children with epilepsy.
• Results suggest that comparisons of composite scores of the QOLCE-55 are meaningful in terms of their clinical relevance to health practitioners and families of children with epilepsy
Health-related quality of life (HRQL) can be regarded as the most important health outcome in any chronic health condition.
1 HRQL has been defined as the "subjective and objective impact of dysfunction associated with an illness or injury, medical treatment, and health care policy. " 2 This multidimensional construct captures a patients' physical, psychological, and social well-being, in addition to their disease state. The evaluation of HRQL as a key patientreported outcome is an active area of research in pediatric epilepsy. A substantial body of literature has documented the detrimental consequences of epilepsy in children on multiple domains of HRQL. [3] [4] [5] [6] Consequently, the primary goal of the management of pediatric epilepsy is to both improve and prevent potential declines in patient HRQL. 7 Considerable effort has been dedicated to developing comprehensive and psychometrically robust measures of HRQL for children with epilepsy. [8] [9] [10] [11] [12] One of the most widely used epilepsy-specific instruments is the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE). The original QOLCE, a 76-item parent-rated instrument, was developed and validated in an Australian sample. 11 It was later adapted in a North American population as a 79-item instrument with 16 subscales covering five main domains: physical activity (physical restrictions and energy/fatigue), cognition (attention/concentration, memory, language, and other cognition), well-being (depression, anxiety, control/ helplessness, and self-esteem), social activity (social interactions, social activities, and stigma), and behavior. 12 Despite its widespread use, the QOLCE has important limitations, 8, 13 including the absence of a formal examination of the factor structure during scale development, as well as low internal consistency reliability for some of the smaller subscales (e.g., stigma). Correspondingly, a shortened 55-item version, the QOLCE-55, was recently developed and validated in a sample of children with new-onset epilepsy. 8 As depicted in Figure 1 , the higher-order factor structure of the QOLCE-55 aligns well with current conceptualizations of HRQL, 2 signifying that HRQL is a multifaceted construct that assesses four domains of functioning: physical, emotional, social, and cognitive. The reduction of items resulted in a more robust psychometric profile with enhanced internal consistency reliability among the subscales. 8 Further validation of the QOLCE-55 was carried out within the same sample of children with new-onset epilepsy by testing for measurement equivalence. 9 This technique is a statistical approach that assesses the degree to which psychometric properties of observed scale items are generalizable across groups as a means of ensuring that the same underlying construct is being measured in the same way. 9 If measurement equivalence has been established for an instrument, it can be inferred that comparisons of group scores (e.g., mean differences) are meaningful.
14 The findings of the aforementioned study suggest that items of the QOLCE-55 are perceived similarly across groups stratified by age, sex, and time (individuals assessed at diagnosis and again 2 years later) 9 in children with new-onset epilepsy. Given that the QOLCE-55 was developed and validated in a sample of children with new-onset epilepsy, the primary objective of the current study was to extend the validity of the QOLCE-55 to children with drug-resistant epilepsy, which is defined as failure to achieve sustained seizure freedom with adequate trials of two or more tolerated and appropriately chosen antiseizure medications. 15 To do so included confirmation of the higher-order factor structure ( Fig. 1 ) and further examination of convergent and divergent validity. The secondary objective was to empirically test the external validity of the QOLCE-55 by examining measurement equivalence across the current sample of children with drug-resistant epilepsy and a sample of children with new-onset epilepsy. 7 
Methods

Participants
Data (N = 136) were collected as part of the Impact of Pediatric Epilepsy Surgery on Health-Related Quality of Life Study (PEPSQOL), a multicenter prospective cohort study. 3 Participants were recruited during the period of evaluation of candidacy for epilepsy surgery from eight centers across Canada who treat children with drug-resistant epilepsy. Patients with drug-resistant, localization-related epilepsy (assessed by clinical semiology and/or electroencephalography) aged 4-18 years were eligible for inclusion in the study. Exclusion criteria included inability to complete the questionnaires (e.g., non-English-speaking caregivers); prior resective surgery, past or planned nonresective (e.g., corpus callosotomy) epilepsy surgery, or vagus nerve stimulator placement; and neurometabolic disorders, neurodegenerative disorders, and genetic epilepsy syndromes such as genetic generalized epilepsy and epileptic encephalopathies.
The current study utilized baseline data from the longitudinal PEPSQOL study, a presurgical sample including patients deemed eligible for surgery and those deemed ineligible. At baseline, all children are either in the process of undergoing or have undergone presurgical evaluation. The response rate was 76%.
To examine measurement equivalence of the QOLCE-55 across the current sample of children with drug-resistant epilepsy and a sample of children with newly diagnosed epilepsy, baseline data from children enrolled in the HealthRelated Quality of Life of Children with Epilepsy Study (HERQULES) were included. HERQULES was a multicenter prospective cohort study of 4-to 12-year-old children with new-onset epilepsy that examined trajectories and determinants of HRQL during the first 2 years after diagnosis. Children were recruited from pediatric neurology outpatient clinics in Canada. A more detailed review of the HERQULES sample and methodology is available. 7 
Measures
The QOLCE-55 is a modified version of the original 76-item QOLCE, which assesses parent-reported HRQL of children with epilepsy aged 4-18 years of age. It is selfadministered. As depicted in Figure 1 , the four main domains of the QOLCE-55 include cognitive functioning (22 items), emotional functioning (17 items), social functioning (7 items), and physical functioning (9 items). Items are rated on a five-point Likert scale, 0 = very often; 1 = fairly often; 2 = sometimes; 3 = almost never; and 4 = never. The composite HRQL score is the unweighted average of the four subscales, ranging from 0 to 100. Higher scores indicate better HRQL. The QOLCE-55 has excellent psychometric properties and is freely available. 8, 9 In the PEPSQOL sample, the "not applicable" response option was excluded from QOLCE items due to Research Electronic Data Capture (REDCap) system constraints, which would have impacted the calculation of both sub-scale and overall totals. REDCap is a secure web application for managing online databases.
The KIDSCREEN-27 is a dual child-and parent-rated generic HRQL instrument 16 that measures five dimensions: physical well-being (five items), psychological well-being (seven items), parental relations and autonomy (seven items), social support and peers (four items), and school environment (four items). The KIDSCREEN has been validated for the ages of 8-18 years in children with a variety of chronic illnesses and developmental disorders. [17] [18] [19] Rasch scores are computed for each dimension and are transformed into values with a mean of 50 and a standard deviation of 10. Higher scores indicate better HRQL and wellbeing. KIDSCREEN-27 has good internal consistency reliability (a = 0.79-0.84), good convergent and discriminant validity, and good test-retest reliability (r = 0.61-0.74). 16 The physical and psychological well-being subscales were Table 2 . Epilepsia ILAE used for the current analyses. The former contains items pertaining to children's physical activities and health (e.g., Thinking about the last week: have you felt full of energy?), whereas the latter includes items that capture general mood and feelings about oneself (e.g., Thinking about last week: have you felt lonely?).
Statistical analyses
Analyses were conducted on baseline PEPSQOL data using Mplus 6.12 (Muth en & Muth en). The established higher-order factor structure ( Fig. 1) was tested using confirmatory factor analysis. Weighted least squares means and variance adjusted (WLSMV) estimation was used to obtain all estimates. In Mplus, the WLSMV produces and analyzes a polychoric correlation matrix and an associated weight matrix. The adequacy of model fit was evaluated using the following statistics to assess the degree of fit between estimated and observed variance, as recommended by Tabachnik and Fidell, 20 Bentler and Bonett, 21 20 To assess reliability, internal consistency for summary measures of the original QOLCE and the QOLCE-55 were estimated using Cronbach's alpha. Estimates equal to or >0.70 were considered satisfactory. 25 The estimates are not directly comparable between the original QOLCE and the QOLCE-55, given that the two versions have a different number of items. To account for this discrepancy, the SpearmanBrown prophecy formula 26 was calculated to determine the reliability of the QOLCE-55 if it were to have 76 items while upholding the current correlations of items between each.
Convergent validity was examined by estimating the association between subscale scores of the QOLCE-55 (physical functioning, emotional functioning) and relevant subscales of the parent-rated KIDSCREEN-27 (physical well-being, psychological well-being) using Spearman rho (q). In line with Tabachnik and Fidell, 20 a positive correlation >0.32 is evidence of convergent validity, suggesting at minimum 10% shared variance between two scales. Furthermore, divergent validity was examined by estimating the association between dissimilar scales of the QOLCE-55 and KIDSCREEN-27 (physical functioning-psychological well-being, emotional functioning-physical well-being). Weak correlations provide evidence of divergent validity, as they imply little to no relationship between two scales. 20 Specific thresholds for correlations as indicators of divergent validity are rarely quantified in the literature.
Measurement equivalence of the QOLCE-55 was evaluated using multiple-group confirmatory factor analysis (drug-resistant epilepsy vs. new-onset epilepsy). To establish measurement equivalence, two criteria were assessed: (1) model fit at each level of testing, and (2) change in fit indices from the less constrained model to the more constrained model. Model fit was deemed adequate if two of the three fit indices (v 2 goodness-of-fit, CFI, RMSEA) met cut-points that were established a priori. 27, 28 The cut points were as follows: v 2 goodness-of-fit p > 0.05; CFI >0.900 is acceptable, >0.950 is excellent; and RMSEA<0.08 is acceptable, <0.06 is excellent. 23, 29, 30 Furthermore, at any given level of testing, changes in fit indices from the less to the more constrained model were deemed adequate if a priori cut-points for statistical (Dv 2 ) and practical (DCFI or DRMSEA) significance were not exceeded. The cut-points for change in model fit indices were as follows: Dv 2 p > 0.05; DCFI ≤ 0.010; DRMSEA <0.015. 31 Because the Dv 2 is sensitive to imbalances in sample sizes, 32 a simple random sample of 136 patients was drawn from HER-QULES (N = 374) to match the sample size of PEPSQOL.
Results
Sample (N = 136) characteristics are presented in Table 1 . Children had a mean age of 11.58 AE 4.00 years and 80 (58.8%) were male. The mean age at seizure onset was 6.14 AE 4.04 years and the average duration of epilepsy was 5.40 AE 3.96 years. Fifty-three percent of the sample experienced seizures daily or weekly. Most of the caregivers completing the questionnaires were aged between 40 and 49 years (51.5%), were female (83.8%), and were employed (65.4%). Characteristics of the sample of children with new-onset epilepsy are presented in Table 1 .
Higher-order factor structure
The higher-order factor structure of the QOLCE-55 was validated in the current sample using confirmatory factor analysis. The model demonstrated adequate fit to the baseline data: CFI = 0.948; TLI = 0.946; RMSEA = 0.060 (90% CI 0.054-0.065); WRMR = 1.247. The higher-order summary factor model is presented in Figure 2 , and the standardized parameter estimates for the first-order items are presented in Table 2 . All of the items significantly loaded onto their respective first-order factors (cognitive, emotional, social and physical functioning), with the exception of item 6 on the physical functioning scale (PF06; see Table 2 ). The four first-order factors loaded onto a single higher-order factor (overall HRQL). Higher-order factor loadings were strong, ranging from k = 0.74 to 0.81, (p < 0.001 for all).
Internal consistency reliability and convergent/ divergent validity
Results of the internal consistency reliability for the original QOLCE and the QOLCE-55 are presented in Table 3 . Internal consistency reliability was found to be good for each subscale of the QOLCE-55, with estimates of Cronbach's alpha ranging from 0.82 to 0.97. Internal consistency reliability for the overall measure was excellent a = 0.97. To account for the discrepancy in the number of items between the original QOLCE and the QOLCE-55, the Spearman-Brown prophecy formula was calculated to determine the reliability of the QOLCE-55 if it were to have 76 items while upholding the current correlations of items between each. The QOLCE-55 (a = 0.98) maintained the excellent internal consistency reliability associated with the original QOLCE (a = 0.97). Inter-item correlation matrices for each subscale of the QOLCE-55 are presented in Appendix S1, and average inter-item correlations are detailed in Table 3 .
Convergent validity was examined by estimating the association between subscale scores of the QOLCE-55 (physical functioning, emotional functioning) and relevant subscales of the KIDSCREEN-27 (physical well-being, psychological well-being) using Spearman rho (q). Correlations were moderate to strong: QOLCE-55 physical functioning score to KIDSCREEN-27 physical well-being score (q = 0.43); QOLCE-55 emotional functioning score to KIDSCREEN-27 psychological well-being score (q = 0.75). For divergent validity, correlations examined were weak to moderate: QOLCE-55 physical functioning score to KIDSCREEN-27 psychological well-being score (q = 0.25); QOLCE-55 emotional functioning score to KIDSCREEN-27 physical well-being score (q = 0.42).
Measurement equivalence by sample (drug-resistant epilepsy vs. new-onset epilepsy)
Given that item PF06 did not load significantly onto its respective factor in the PEPSQOL sample, this item was removed from the multiple-group confirmatory factor analysis. At the configural level, the first step of measurement equivalence testing, the factor structure of the QOLCE-55, was modeled simultaneously with no parameter constraints in the PEPSQOL and HERQULES samples. At first attempt, the model did not converge. Upon close examination of the analysis summary, it was determined that response profiles for item PF04 varied substantially across samples. Consequently, this item was removed from the model. Furthermore, we collapsed response categories for items with low endorsement rates (<5%), an approach to handle issues of model nonconvergence that is well supported in the literature. [32] [33] [34] As seen in Table 4 , model fit was adequate according to the predetermined cut-offs: v 2 (2,646) = 3,686.2, p < 0.001; CFI = 0.956; RMSEA = 0.054 (0.050, 0.058). At the level of weak invariance, parameter constraints were placed first on item factor loadings, followed by firstorder factor loadings. When item factor loadings were constrained (model 2), there was evidence of nonequivalence (Dv 2 (49) = 162.7, p < 0.001). Modification indices suggested that removing the constraints on eight item factor loadings would improve model fit: EF02, EF03, EF04, EF06, EF11, and EF12 (see Table 2 for item details). Once these constraints were removed, changes in model fit indices were within acceptable limits to continue testing (model 3: Dv 2 (41) = 51.9, DCFI = 0.001, DRMSEA = À0.001). When first-order factor loadings were constrained, there was no significant worsening of model fit (model 4). In the next stage of testing, strong invariance, item thresholds, followed by first-order intercepts were constrained across groups. There was evidence of nonequivalence when item thresholds were constrained (Dv 2 (134) = 764.4, p < 0.001), as well as first-order intercepts (Dv 2 (4) = 70.6, p < 0.001). Modification indices suggested that model fit would be improved by removing constraints on 29 item thresholds (18 items, see Table 4 , model 6) and two first-order intercepts (cognitive functioning and physical functioning), as well as including three covariances in the model (EF07 with EF08, PF07 with PF08, EF15 with EF16). After implementing these modifications, change in model fit indices were acceptable (model 6: Dv item residuals would improve model fit: CF01, CF02, CF06, CF08, CF11, CF13, CF14, CF16, CF17, CF18, CF22, EF01, EF02, EF05, EF06, EF16, EF17, SF02, SF03, SF07, PF01, PF02, PF03, PF07. Change in model fit indices were acceptable once these constrains were removed (model 10: Dv 2 (29) = 42.1, DCFI = 0.003, DRMSEA = À0.002). At the final level of testing, factor variances were constrained and measurement equivalence was established (model 11). A list of invariant items is presented in Table 2 .
Discussion
The evaluation of HRQL as a key patient-reported outcome is an active area of research in pediatric epilepsy. As such, considerable effort has been dedicated to developing comprehensive and psychometrically robust measures of HRQL for children with epilepsy. [8] [9] [10] [11] [12] The current study aimed to extend the validation of the QOLCE-55 to a sample of children with drug-resistant epilepsy. As a whole, the findings indicate that the QOLCE-55 is a reliable and valid instrument that can be used as a time-saving alternative to the full QOLCE.
The higher-order factor structure of the QOLCE-55 was confirmed in the current sample of children with drug- Higher-order summary factor model of the QOLCE-55. All parameter estimates and R 2 values shown were standardized and significant at p < 0.001. For simplicity, first-order items were not included. Epilepsia ILAE resistant epilepsy. Echoing current conceptualizations of HRQL, 2,8 the factor structure suggests that HRQL is a broad, multidimensional construct that assesses functioning across four domains: physical, emotional, social, and cognitive. All of the items significantly loaded onto their respective domain of function, with the exception of item PF06: (Stayed out overnight [with friends or family]?). Further, item PF04, Gone swimming? (i.e., swam independently), approached nonsignificance. It is possible that, due to the increased severity of epilepsy in the current sample, sleeping away from home may occur much less frequently and thus may not be a strong indicator of physical functioning in children with drug-resistant epilepsy. Similarly, this group of children may experience fewer opportunities to learn to swim or to swim independently due to heightened safety concerns. These postulations are supported by recent systematic and critical reviews on experiences of individuals with epilepsy, 35, 36 indicating that children report incessant parental overprotectiveness and constant monitoring; restrictions to physical activity (e.g., gymnastics, school trips) placed on children by teachers, families and practitioners; as well as limitations to social freedom that can result in children "giving up" on participating in certain social activities.
Partial measurement equivalence of the QOLCE-55 was demonstrated through to the level of strict invariance (item residuals/factor variances). Full measurement equivalence evaluates whether every parameter (e.g., loadings, thresholds, residuals) is invariant across groups. It has been suggested that full equivalence is not pragmatic in practice, as the requirement that all elements must be equal across groups is too stringent 37 and unnecessary for valid comparisons to be made. 38, 39 Correspondingly, partial equivalence requires that at least two items per latent variable (domains of function and overall HRQL, in our case) are equivalent to allow for valid comparisons across groups or time points. 38, 39 In line with these arguments, our results suggest that invariant items of the QOLCE-55 are perceived similarly across children with new-onset and drug-resistant epilepsy. In addition, comparisons of composite scores of the QOLCE-55 are meaningful in terms of their clinical relevance to health practitioners and families of children with epilepsy.
Caveats of the study methodology must be considered. PEPSQOL participants were recruited during the period of evaluation of candidacy for epilepsy surgery. Although the sample included both surgical and nonsurgical patients at baseline, it may not be representative of all children with drug-resistant epilepsy. Furthermore, the exclusion of the "not applicable" response option from QOLCE-55 items in the PEPSQOL sample was not ideal, as it limited respondents' options and imposed methodologic variability between the two samples of children with epilepsy. It is possible that this may have contributed to convergence issues at the configural level of testing, as well as the resulting decision to collapse response categories due to item proportions. As evidenced earlier, our results remain clinically and practically relevant to the pediatric epilepsy community; however, greater attention should be paid to this discrepancy for those interested in psychometric outcomes. In addition, the Item achieved equivalence (see Table 4 ).
b
For measurement equivalence testing, we collapsed response categories for items with low endorsement rates (>5%); an approach to handle issues of model non-convergence. Table 3 . Internal consistency reliability of the original QOLCE and the QOLCE-55 (Cronbach's alpha). QOLCE-55 is a parent-report measure of child HRQL and, as such, issues of informant discordance (parent vs. child) could not be addressed in the current study. Investigations of informant discrepancy in measures of child HRQL more broadly (e.g., children with other chronic illnesses and healthy controls) have yielded equivocal findings, 3 while research devoted to examining this reporting issue within childhood-onset epilepsy has demonstrated discordance between child and parent-proxy reports. 40 There remains a pressing need to identify child and caregiver factors that explain variations in parent-child discrepancies, which can be accomplished by leveraging dyadic multilevel modeling approaches using more generic HRQL measures that capture both parent and child reports.
Future directions of this work are recommended to further extend the validation of the QOLCE-55. Tests of measurement equivalence across groups stratified by clinical aspects of epilepsy (e.g., intelligence quotient [IQ], cognitive or behavioral comorbidities, type of seizure, seizure severity) are encouraged, as these important constructs may underlie convergences in item interpretation. 9 Relatedly, there are currently discordant findings in the literature in terms of the utility of the full-scale QOLCE in assessing HRQL in children with intellectual disability, 13 thus highlighting an important avenue of investigation through which multiple group confirmatory factor analysis could be leveraged to assess measurement equivalence of the QOLCE-55 by IQ (e.g., IQ < 50 vs. IQ > 50) or by cognitive comorbidity. Italicized text describes the model parameters that were constrained at each step of the testing process. The parameters in parentheses are those that contributed to model misfit (i.e., were noninvariant) and were thus freed to proceed with model testing. A description of the criteria assessed to establish measurement equivalence is presented in the Statistical analysis (Methods) section of the research article. Overall, partial measurement equivalence of the QOLCE-55 was demonstrated through to the level of strict invariance (item residuals/factor variances). The results suggest that invariant items of the QOLCE-55 are perceived similarly across children with new-onset and drug-resistant epilepsy. A list of invariant items is presented in Table 2 . Furthermore, comparisons of composite scores of the QOLCE-55 are meaningful in terms of their clinical relevance to health practitioners and families of children with epilepsy.
a Not statistically significant; b p < 0.001. Finally, there is value in examining the possibility of a shorter measure (e.g., 10-20 items) with the goal of further reducing respondent burden in research and clinical settings.
Conclusion
In total, the present findings suggest that the shortened QOLCE-55 can be effectively used to assess HRQL in children with drug-resistant epilepsy. Results of our study provide support for the factor structure of the QOLCE-55 and contribute to its robust psychometric profile as a reliable and valid measure. The QOLCE-55 may be of important use in cost-and time-intensive research in clinical medicine, health services, and social sciences, which often include extensive test batteries. Furthermore, epileptologists and other health practitioners aiming to monitor treatment progress of patients can consider the QOLCE-55 as a viable option to reduce both respondent burden and time-consuming assessment.
